Intratumoral Tcf1+ PD-1+ CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy I Siddiqui, K Schaeuble, V Chennupati, SAF Marraco, S Calderon-Copete, ... Immunity 50 (1), 195-211. e10, 2019 | 1083 | 2019 |
Defining ‘T cell exhaustion’ CU Blank, WN Haining, W Held, PG Hogan, A Kallies, E Lugli, RC Lynn, ... Nature Reviews Immunology 19 (11), 665-674, 2019 | 1069 | 2019 |
T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections DT Utzschneider, M Charmoy, V Chennupati, L Pousse, DP Ferreira, ... Immunity 45 (2), 415-427, 2016 | 847 | 2016 |
The MHC reactivity of the T cell repertoire prior to positive and negative selection J Zerrahn, W Held, DH Raulet Cell 88 (5), 627-636, 1997 | 429 | 1997 |
Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory G Jeannet, C Boudousquié, N Gardiol, J Kang, J Huelsken, W Held Proceedings of the National Academy of Sciences 107 (21), 9777-9782, 2010 | 379 | 2010 |
Inactivation of Notch1 in immature thymocytes does not perturb CD4 or CD8 T cell development A Wolfer, T Bakker, A Wilson, M Nicolas, V Ioannidis, DR Littman, ... Nature immunology 2 (3), 235-241, 2001 | 376 | 2001 |
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer JC Dudda, B Salaun, Y Ji, DC Palmer, GC Monnot, E Merck, ... Immunity 38 (4), 742-753, 2013 | 343 | 2013 |
The β-catenin–TCF-1 pathway ensures CD4+ CD8+ thymocyte survival V Ioannidis, F Beermann, H Clevers, W Held Nature immunology 2 (8), 691-697, 2001 | 331 | 2001 |
Two waves of recombinase gene expression in developing thymocytes. A Wilson, W Held, HR MacDonald The Journal of experimental medicine 179 (4), 1355-1360, 1994 | 328 | 1994 |
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand–expressing tumor cells JD Coudert, J Zimmer, E Tomasello, M Cebecauer, M Colonna, E Vivier, ... Blood 106 (5), 1711-1717, 2005 | 293 | 2005 |
Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I‐specific Ly49 receptors DH Raulet, W Held, I Correa, JR Dorfman, MF Wu, L Corral Immunological reviews 155 (1), 41-52, 1997 | 288 | 1997 |
Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin G Jeannet, M Scheller, L Scarpellino, S Duboux, N Gardiol, J Back, ... Blood, The Journal of the American Society of Hematology 111 (1), 142-149, 2008 | 272 | 2008 |
Cis association of Ly49A with MHC class I restricts natural killer cell inhibition MA Doucey, L Scarpellino, J Zimmer, P Guillaume, IF Luescher, C Bron, ... Nature immunology 5 (3), 328-336, 2004 | 239 | 2004 |
Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission W Held, GA Waanders, AN Shakhov, L Scarpellino, H Acha-Orbea, ... Cell 74 (3), 529-540, 1993 | 239 | 1993 |
Regulation of γδ Versus αß T Lymphocyte Differentiation by the Transcription Factor SOX13 HJ Melichar, K Narayan, SD Der, Y Hiraoka, N Gardiol, G Jeannet, ... Science 315 (5809), 230-233, 2007 | 224 | 2007 |
Allelic Exclusion of Ly49-family Genes Encoding Class I MHC-specific Receptors on NK Cells DR W Held, J Roland Nature 376, 355-8, 1995 | 224 | 1995 |
TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation D Wieland, J Kemming, A Schuch, F Emmerich, P Knolle, ... Nature communications 8 (1), 15050, 2017 | 213 | 2017 |
Natural killer cell receptors: the offs and ons of NK cell recognition DH Raulet, W Held Cell 82 (5), 697-700, 1995 | 211 | 1995 |
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways JD Coudert, L Scarpellino, F Gros, E Vivier, W Held Blood, The Journal of the American Society of Hematology 111 (7), 3571-3578, 2008 | 199 | 2008 |
The role of the NKG2D receptor for tumor immunity JD Coudert, W Held Seminars in cancer biology 16 (5), 333-343, 2006 | 199 | 2006 |